Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris results of the international multicenter angina exercise (IMAGE) study

Uusitalo, 1986, Metoprolol, nifedipine and the combination in stable effort angina pectoris, Am J Cardiol, 57, 733, 10.1016/0002-9149(86)90604-1 Kostuk, 1987, Comparative effects of calcium entry-blocking drugs, β-blocking, drugs, and their combination in patients with chronic stable angina, Circulation, 75, V-114 Akhras, 1991, Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina, Lancet, 338, 1036, 10.1016/0140-6736(91)91900-F Kawanishi, 1992, Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine. propranolol and their combination, J Am Coll Cardiol, 19, 409, 10.1016/0735-1097(92)90499-D Broustet, 1987, Mono- or combination therapy for stable angina pectoris, J Cardiovasc Pharmacol, 10, 538 Strauss, 1988, Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina, Ann Intern Med, 109, 570, 10.7326/0003-4819-109-7-570 Chan, 1988, The role of nitrates, beta blockers, and calcium an,agonists in stable angina pectoris, Am Heart J, 116, 838, 10.1016/0002-8703(88)90346-8 Packer, 1989, Combined beta-adrenergic and calcium-entry blockade in angina pectoris, N Engl J Med, 320, 709, 10.1056/NEJM198903163201107 Schulman, 1994, Patient selection and definition of study endpoints, 121 Epstein, 1981, Dynamic coronary tone in the precipitation, exacerbation and relief of angina pectoris, Am J Cardiol, 48, 797, 10.1016/0002-9149(81)90160-0 Benfield, 1986, Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischemic heart disease and related cardiovascular disorders, Drugs, 31, 376, 10.2165/00003495-198631050-00002 McIlwraith, 1980, Effect of nifedipine on exercise tolerance in angina pectoris, Br Heart J, 44, 335, 10.1136/hrt.44.3.335 Stone, 1990, Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms, Circulation, 82, 1962, 10.1161/01.CIR.82.6.1962 Borzak, 1993, Discordance between effects of anti-ischcmic therapy on ambulatory ischemia, exercise, performance and anginal symptoms in patients with stable angina pectoris, J Am Coll Cardiol, 21, 1605, 10.1016/0735-1097(93)90375-B Savonitto S. Merlim PA. Clinical value of anginal symptoms and their assessment in drug trials. In Ref. 9:15–30. Ardiasino, 1995, Selection of medical treatment for stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study, J Am Coll Cardiol, 25, 1516, 10.1016/0735-1097(95)00042-3 Glasser, 1991, Exposing patients with chronic, stable, exertionai angina to placebo periods in drug trials, JAMA, 265, 1550, 10.1001/jama.1991.03460120064037 Thadam, 1991, Double-blind, dose-response, placebo-controlled multicenter study of nisoldipioe. A new secondgeneration calcium-channel blocker in angina pectoris, Circulation, 84, 2398, 10.1161/01.CIR.84.6.2398 Waters, 1991, Proischemic complications of dihydropyridine calcium channel blockers, Circulation, 84, 2598, 10.1161/01.CIR.84.6.2598